Search for: "Ariad Pharmaceuticals Inc."
Results 61 - 80
of 103
Sort by Relevance
|
Sort by Date
10 Dec 2009, 9:50 pm
By Donald Zuhn -- On Monday, an en banc panel of the Federal Circuit heard oral argument in Ariad Pharmaceuticals, Inc. v. [read post]
9 Dec 2009, 9:24 pm
Noonan -- Oral argument in Ariad Pharmaceuticals, Inc. v. [read post]
9 Dec 2009, 3:59 pm
Teva Pharmaceuticals USA Inc. [read post]
7 Dec 2009, 7:51 am
This afternoon, the 11 active judges of the Federal Circuit will hear argument in Ariad Pharmaceuticals, Inc. v. [read post]
6 Dec 2009, 9:59 pm
By Donald Zuhn -- In anticipation of tomorrow's oral argument in the rehearing en banc of Ariad Pharmaceuticals, Inc. v. [read post]
2 Dec 2009, 5:11 pm
In probably the most significant case since In re Bilski, the en banc Federal Circuit in Ariad Pharmaceuticals v. [read post]
2 Dec 2009, 4:31 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Venezuela to examine all pharmaceutical patents (IP tango) General World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Biodiversity negotiations need to allow for flexibility in business, industry says (IP Watch) Brazilian government tailors a bill… [read post]
1 Dec 2009, 3:40 pm
§ 112, first paragraph, in an amicus curiae brief filed in the rehearing en banc of Ariad Pharmaceuticals, Inc. v. [read post]
25 Nov 2009, 9:59 pm
Noonan -- The Intellectual Property Owners Association (IPO) has filed an amicus brief in the rehearing en banc of Ariad Pharmaceuticals, Inc. v. [read post]
24 Nov 2009, 9:59 pm
By Donald Zuhn -- In anticipation of the upcoming oral argument in the rehearing en banc of Ariad Pharmaceuticals, Inc. v. [read post]
23 Nov 2009, 9:59 pm
By Donald Zuhn -- With oral argument in the rehearing en banc of Ariad Pharmaceuticals, Inc. v. [read post]
19 Nov 2009, 9:59 pm
Holman, Associate Professor of Law at the University of Missouri-Kansas City (and proprietor of Holman's Biotech IP Blog), has filed an amicus brief in support of neither party in Ariad Pharmaceuticals, Inc. v. [read post]
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA Inc. et al. [read post]
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA Inc. et al. [read post]
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA Inc. et al. [read post]
16 Nov 2009, 9:59 pm
By Donald Zuhn -- Last week, Defendant-Appellant Eli Lilly & Co. filed its principal brief for the rehearing en banc of Ariad Pharmaceuticals, Inc. v. [read post]
10 Nov 2009, 9:59 pm
By Donald Zuhn -- With oral argument before the Supreme Court in In re Bilski now concluded, patent practitioners can begin to turn their attention toward the next big patent case awaiting oral argument: the Federal Circuit's en banc rehearing of Ariad Pharmaceuticals, Inc. v. [read post]
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces settlement… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
